New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now?

被引:98
作者
Feng, Si-Shen
机构
[1] Natl Univ Singapore, Fac Engn, Dept Chem & Biomol Engn, Nanosci & Nanoengn Initiat, Singapore 117576, Singapore
[2] Natl Univ Singapore, Fac Engn, Div Bioengn, Singapore 117576, Singapore
关键词
cancer; nanotechnology; chemotherapeutic engineering; drug delivery; nanobiotechnology; nanomedicine;
D O I
10.2217/17435889.1.3.297
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
No substantial progress has really been observed during the past 50 years in fighting cancer, and the way we currently detect and treat cancer is similar to 30 years ago. Cancer nanotechnology will change the situation radically. Progress in developing nanoparticles of biodegradable polymers for new-concept chemotherapy is reviewed here by using the in vitro and in vivo experimental results obtained in my laboratory as a proof-of-concept demonstration. The prospects of using multifunctional nanoparticles for targeting, diagnosing, therapy delivery and result-reporting as a possible solution for cancer detection and treatment are also described. I believe that cancer will become curable using targeted and sustained chemotherapy by such nanoparticles at the earliest stage of disease. High efficacy and low side effects can be achieved, since high drug concentrations can be delivered selectively to the cancer cells, leaving healthy cells untouched. Thus, the required amount of the drug can be minimized.
引用
收藏
页码:297 / 309
页数:13
相关论文
共 67 条
[1]
Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]
Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO
[3]
2-F
[4]
Clinical aspects of drug delivery to tumors [J].
Au, JLS ;
Jang, SH ;
Wientjes, MG .
JOURNAL OF CONTROLLED RELEASE, 2002, 78 (1-3) :81-95
[5]
Determinants of drug delivery and transport to solid tumors [J].
Au, JLS ;
Jang, SH ;
Zheng, J ;
Chen, CT ;
Song, S ;
Hu, L ;
Wientjes, MG .
JOURNAL OF CONTROLLED RELEASE, 2001, 74 (1-3) :31-46
[6]
Toward selection of internalizing antibodies from phage libraries [J].
Becerril, B ;
Poul, MA ;
Marks, JD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 255 (02) :386-393
[7]
Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: The effect of mucus on particle adsorption and transport [J].
Behrens, I ;
Pena, AIV ;
Alonso, MJ ;
Kissel, T .
PHARMACEUTICAL RESEARCH, 2002, 19 (08) :1185-1193
[8]
In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel [J].
Chen, DB ;
Yang, TZ ;
Lu, WL ;
Zhang, Q .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (11) :1444-1447
[9]
Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs [J].
Dong, YC ;
Feng, SS .
BIOMATERIALS, 2004, 25 (14) :2843-2849
[10]
Poly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs [J].
Dong, YC ;
Feng, SS .
BIOMATERIALS, 2005, 26 (30) :6068-6076